NVCRHealthcareMedical Devices — Oncology·Sep 3, 2026·1 min read

NVCR: FY25 Deep Dive

NovoCure FY25 at $655M. NI $-136M; EPS $-1.22.

NVCR: FY25 Deep Dive

FY25 revenue $655M; OI $-154M; NI $-136M; EPS $-1.22.

NovoCure FY25 (Dec 31, 2025) at $655M revenue. OpInc $-154M; NI $-136M; EPS $-1.22. Medical Devices — Oncology.

Related:NVCR

Want deeper analysis?

Ask drillr anything about NVCR — powered by SEC filings, earnings calls, and real-time data.

Try drillr.ai for free